Recently, after authoritative review and public announcement, Guangsen Medical has been officially recognized as a technology oriented small and medium-sized enterprise for 2025 (the second batch of planned technology oriented small and medium-sized enterprises in Jiangsu Province for 2025). This honor not only highly recognizes the company's deep cultivation of core areas and adherence to technological innovation, but also marks a new level of technological research and development, achievement transformation, and sustainable development capabilities.

The recognition criteria for technology-based small and medium-sized enterprises cover multiple core dimensions such as research and development investment, proportion of technical personnel, intellectual property reserves, and achievement transformation efficiency, with strict and comprehensive audits. This successful selection is due to the company's profound practice of "innovation is the core competitiveness" since its establishment. We always take technology research and development as the engine, form a professional R&D team, and continue to deeply cultivate sub fields. We have achieved multiple independent technological achievements in the field of [complementary core technology directions, such as intelligent device research and development/new material applications], and have accumulated [complementary patents/software copyrights] intellectual property rights, building a technical barrier that combines depth and breadth. At the same time, the company has been increasing its R&D investment year by year, achieving precise alignment between technological innovation and market demand through equipment upgrades, process optimization, and industry university research cooperation, laying a solid foundation for certification.

This recognition not only brings honor endorsement, but also means that the enterprise will fully enjoy policy dividends and development opportunities. According to relevant policies, the company can enjoy tax incentives of 100% additional deduction for research and development expenses, effectively reducing operating costs; Priority support will be given to applications for government special support funds and technology finance loans, injecting financial momentum into subsequent research and development upgrades. More importantly, the identity of technology-based small and medium-sized enterprises will significantly enhance the company's brand credibility, forming a competitive advantage in bidding, partner expansion, and talent attraction. At the same time, it also provides a key springboard for subsequent applications for higher-level qualifications such as high-tech enterprises and "specialized, refined, unique, and new" enterprises.

Honor is not only recognition, but also responsibility and motivation. In the future, Guangsen Medical will take this recognition as a new starting point, continue to focus on core technological innovation, deepen intellectual property layout and achievement transformation, and transform policy dividends into practical results of technological upgrading. We will continue to uphold the concept of "empowering development with technology and driving growth with innovation", and work hard in the [complementary industry] field. We not only need to consolidate our own competitive advantage of "technology+brand+resources", but also contribute to the high-quality development of the industry.

Thank you again to all employees for their unity and strong support from our partners. Standing at a new development node, we will use technology as the spear and innovation as the shield, overcome obstacles in market competition, steadily move forward in industry transformation, and write a more valuable chapter of development!